Veristrat

From WikiMD.com - Food, Medicine & Wellness Encyclopedia

A blood-based test for cancer prognosis


Veristrat is a blood test used in the field of oncology to help determine the prognosis of patients with certain types of cancer, particularly non-small cell lung cancer (NSCLC). This test analyzes the proteomic profile of a patient's blood to classify them into different prognostic groups, which can guide treatment decisions.

Overview[edit | edit source]

Veristrat is a serum-based test that utilizes mass spectrometry to analyze the protein composition of a patient's blood. The test is designed to provide information about the likely course of the disease and the potential benefit of specific chemotherapy regimens. It is particularly used in the context of advanced NSCLC to help oncologists decide whether a patient is more likely to benefit from chemotherapy or targeted therapy.

Mechanism[edit | edit source]

The Veristrat test works by examining the proteomic profile of a patient's blood. It identifies specific patterns of protein expression that are associated with different outcomes in cancer treatment. The test categorizes patients into "Good" or "Poor" prognostic groups based on these patterns. Patients classified as "Good" are more likely to respond positively to certain treatments, while those in the "Poor" group may have a less favorable response.

Clinical Use[edit | edit source]

Veristrat is primarily used in the management of advanced non-small cell lung cancer. It helps in making informed decisions about the use of epidermal growth factor receptor (EGFR) inhibitors and other therapies. By providing prognostic information, Veristrat assists in tailoring treatment plans to the individual needs of patients, potentially improving outcomes and avoiding unnecessary side effects from ineffective treatments.

Advantages[edit | edit source]

One of the main advantages of Veristrat is its non-invasive nature, as it only requires a blood sample. This makes it a convenient option for patients compared to more invasive procedures like biopsy. Additionally, the test provides rapid results, allowing for timely decision-making in the management of cancer.

Limitations[edit | edit source]

While Veristrat offers valuable prognostic information, it is not a diagnostic test and should be used in conjunction with other clinical assessments and diagnostic tools. The test's predictive power is also limited to certain types of cancer and may not be applicable to all patients or cancer types.

Related pages[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD